SBI Securities
FHTX icon

SBI Securities’s Foghorn Therapeutics FHTX Stock Holding History

SBI Securities’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$357 Hold
100
– – ﹤0.01% 3223
2026
Q2 		$488 Hold
100
– – ﹤0.01% 3039
2026
Q1 		$478 Hold
100
– – ﹤0.01% 2907
2025
Q4 		$540 Hold
100
– – ﹤0.01% 2847
2025
Q3 		$489 Hold
100
– – ﹤0.01% 2973
2025
Q2 		$470 Hold
100
– – ﹤0.01% 2992
2025
Q1 		$365 Buy
100
+99
+9,900% +$451 ﹤0.01% 2995
2024
Q4 		$5 Buy
+1
New +$7 ﹤0.01% 3996

Other funds holding FHTX

Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return
True Wealth Design
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

SBI Securities's FHTX Position: Q3 2026 in Review

SBI Securities held its Foghorn Therapeutics (FHTX) position steady in Q3 2026 at 100 shares worth $357. The position accounts for ﹤0.01% of the portfolio, ranked #3223.

SBI Securities first reported a position in FHTX in Q4 2024 and has held it in 8 quarters since. The position peaked at $540 in Q4 2025. 9 funds tracked by Wall St. Rank hold FHTX as of Q3 2026.

  • SBI Securities held 100 shares of Foghorn Therapeutics worth $357 as of Q3 2026.
  • SBI Securities left its Foghorn Therapeutics share count unchanged in Q3 2026.
  • Foghorn Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3223 holding.
  • SBI Securities first reported a position in Foghorn Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • SBI Securities's Foghorn Therapeutics position peaked at $540 in Q4 2025.
  • 9 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.